VASH1 and neoplasm: Treatment with antagomir-494 inhibits angiogenesis and reduces tumour growth in vivo [79] Likewise, miR-4530 increases angiogenesis by targeting vasohibin 1 (VASH1) [83,84], while miR-127 was protective for I/R related tissue damage [80].